WASHINGTON, July 4 -- The Center for Regulatory Freedom, a project of the CPAC Foundation, submitted a public comment letter to the U.S. Department of Labor and U.S. Department of Health and Human Services urging immediate action on prescription drug pricing transparency. The letter responds to a request for information regarding the Transparency in Coverage final rules and highlights the impact of pharmacy benefit managers (PBMs) on escalating drug costs. In the correspondence, CRF Director  more ST

WASHINGTON, July 4 -- Milliman, Chicago, Illinois, an actuarial and consulting firm, submitted a public comment letter to the U.S. Department of Labor advocating for improved transparency in prescription drug pricing. The correspondence expressed gratitude for the agency's Request for Information regarding the Prescription Drug Machine-Readable File Requirement and emphasized the importance of actionable data for various stakeholders. The letter to the Office of Health Plan Standards and Compli more ST

WASHINGTON, July 4 -- The Pharmaceutical Care Management Association submitted a public comment letter to three federal agencies regarding the Prescription Drug Machine-Readable Requirement under the Transparency in Coverage Final Rule. In their correspondence, PCMA expressed support for transparency measures that aid patients and healthcare providers but raised objections about specific data disclosures that they argue could lead to increased drug prices. Tim Dube, Senior Vice President, Polic more ST